thalidomide clinical data pronunciation ldmad1 trade names thalomid immunoprin talidex talizer neurosedyn ahfsdrugscom monograph medlineplus a699032 license data euemathalidomide_celgene usfdathalidomide pregnancy category au high risk contraindicated routes administration mouth capsules atc code l04ax02 legal status legal status au s4 prescription ca -only uk pom prescription -only pharmacokinetic data bioavailability 90 protein binding 55 66 r-- s--enantiomers respectively2 metabolism liver minimally cyp2c19-mediated 5-hydroxylation non-enzymatic hydrolysis amide sites2 biological half-life 57.5 hours dose-dependent2 excretion urine faeces2 identifiers iupac 2-2,6-dioxopiperidin-3-yl-2,3-dihydro-1h-isoindole-1,3-dione synonyms -n-phthalimidoglutarimide cas number 50-35-1y pubchem cid 5426 iupharbps 7327 drugbank db01041y chemspider 5233y unii 4z8r6ors6ly kegg d00754y chebi chebi9513n chembl chembl468y echa infocard 100.000.029 chemical physical data formula c13h10n2o4 molar mass 258.23gmol1 3d model jmol interactive image chirality racemic mixture smiles ocn1c2cccnc2ooc3ccccc3c1o inchi inchi1sc13h10n2o4c16-10-6-5-9111714-1015-12187-3-1-2-4-87131519h1-49h5-6h2h141617y keyuejjhqnacjxskw-uhfffaoysa-ny nywhat thisverify thalidomide sold brand immunoprin immunomodulatory drug prototype thalidomide class drugs today thalidomide mainly treatment cancers multiple myeloma complication leprosy thalidomide marketed 1957 west germany trade-name contergan german drug company chemie grnenthal developed sold drug primarily prescribed sedative hypnotic thalidomide claimed cure anxiety insomnia gastritis tension3 nausea alleviate morning sickness pregnant women thalidomide over-the-counter drug west germany october 1 1957 shortly drug sold west germany 5,000 7,000 infants born phocomelia malformation limbs 40 children survived4 world 10,000 cases reported infants phocomelia due thalidomide 50 10,000 survived subjected thalidomide womb experienced limb deficiencies long limbs developed presented stumps effects included deformed eyes hearts deformed alimentary urinary tracts blindness deafness5 negative effects thalidomide led development structured drug regulations control drug development6 contents 1 medical 2 adverse effects 2.1 carcinogenicity 2.2 contraindications 2.3 interactions 2.4 overdose 3 mechanism action 3.1 cereblon crbn 3.2 actions 4 history 4.1 leprosy treatment 4.2 cancer treatment 5 thalidomide analogs 6 society culture 6.1 regulatory approved 6.2 birth defects crisis 6.3 aftermath scandal 6.3.1 germany 6.3.2 united kingdom 6.3.3 australia 6.3.4 canada 6.3.5 united states 6.4 notable cases 6.5 change drug regulations 7 research 8 9 references 10 reading 11 external links medical usesedit pack thalidomide capsules thalidomide number conditions including erythema nodosum leprosum multiple myeloma combination dexamethasone cancers symptoms hivaids crohns disease sarcoidosis graft-versus-host disease rheumatoid arthritis number skin conditions responded usual treatment7 bacterium tuberculosis related leprosy thalidomide helpful cases standard tb drugs corticosteroids sufficient resolve severe inflammation brain89 conclusive evidence thalidomide lenalidomide bring maintain remission crohns disease1011 adverse effectsedit thalidomide side effects polyneuropathy fatigue skin rash venous thromboembolism vte blood clots lead stroke myocardial infarction1213 adverse effects frequency14151617 common affect 1 10 people somnolence drowsiness 40 edema 60 hypotension low blood pressure headache haematuria blood urine arthralgia joint pain myalgia muscle aches increased bilirubin neutropenia 30 leucopenia 15-40 lymphopenia constipation peripheral neuropathy dizziness paraesthesia dysaesthesia common affect 1 10 people pulmonary embolism vomiting dry mouth toxic skin eruption dry skin rash urticaria hives pyrexia fever asthenia interstitial lung disease heart failure depression pneumonia uncommon affect 1 100 people shortness breath tremor rare affect 1 1,000 people increased appetite bradycardia low heart rate tachycardia high heart rate cardiac arrhythmia malaise deep vein thrombosis rare affect 1 10,000 people thrombocytopenia anaemia hypothyroidism reduced libido confusion seizures orthostatic hypotension thromboembolic events bronchospasm intestinal obstruction pruritus itchiness stevens-johnson syndrome toxic epidermal necrolysis facial oedema photosensitivity light sensitivity menstruation abnormalities peripheral neuropathy irreversible results chronic matter months exposure thalidomide16 carcinogenicityedit animal studies demonstrate carcinogenicity rats mice exposed 11 times therapeutic dose thalidomide17 despite concerns secondary malignancies patients multiple myeloma fda issued statement investigating concerns18 clinical trials supported claim major secondary malignancy thalidomide acute myeloid leukaemia19 mhra uk health canada canada issued warnings healthcare professionals regarding risk secondary malignancies due thalidomide exposure2021 contraindicationsedit contraindications include17 known hypersensitivity thalidomide pregnancy breastfeeding patient age 12 years patients unable unwilling comply required contraceptive measures interactionsedit expected pharmacokinetic interactions thalidomide medicines due neutral effects p-glycoprotein p450 cytochromes17 interact sedatives due sedative action17 interact bradycardic agents due bradycardia-inducing effects17 risk peripheral neuropathy increased concomitant treatment agents known peripheral neuropathy17 risk venous thromboembolisms thalidomide increased patients treated oral contraceptives cytotoxic agents including doxorubicin melphalan concurrently17 thalidomide interfere contraceptive effects contraceptives advised women reproductive age means contraception ensure child conceived receiving thalidomide17 overdoseedit eighteen cases overdoses reported date doses 14.4 reported fatalities17 specific antidote overdoses exists treatment purely supportive17 mechanism actionedit precise mechanism action thalidomide unknown mechanisms include anti-angiogenic oxidative stress-inducing effects22 inhibits tnf- il-6 il-10 il-12 production23 modulates production ifn-23 enhances production il-2 il-4 il-5 immune cells23 increases lymphocyte count costimulates cells modulates natural killer cell cytotoxicity23 inhibits nf-b cox-2 activity22 1990 group researchers brazil noted tnf alpha levels leprosy reactional states observed tnf levels decreased patients treatment thalidomide potentially explaining efficacy thalidomide treating enl24 mechanism thalidomides teratogenic action led 2000 research papers proposal 15 16 plausible mechanisms25 angiogenesis critical limb development foetus thalidomide directly inhibit angiogenesis induced bfgf vegf vivo26 teratogenic analogs inhibit angiogenesis nonteratogenic analogs inhibit angiogenesis26 2009 research groups confirmed conclusively loss newly formed blood vessels primary thalidomide teratogenesis developing limbs susceptible immature highly angiogenic vessel network2728 enantiomers thalidomide left s--thalidomide r--thalidomide thalidomide racemic individual enantiomers racemize due acidic hydrogen chiral centre carbon glutarimide ring bonded phthalimide substituent racemization process occur vivo2293031 plan administer purified single enantiomer avoid teratogenic effects likely vain303233 cereblon crbnedit studies shown mechanism action thalidomide involves binding protein cereblon ubiquitin ligase substrate adapter protein34 important limb formation35 proliferative capacity myeloma cells ubiquitin ligases function reducing cellular levels proteins thalidomide shown alter set proteins crbn degrade36 cereblons relevance human congenital defects confirmed studies reduced production cereblon developing chick zebrafish embryos genetic techniques embryos defects similar treated thalidomide interestingly mice treated thalidomide display teratogenicity offspring seen humans37 actionsedit thalidomide binds acts antagonist androgen receptor ar383940 accordance produce gynecomastia sexual dysfunction side effects men414243 dimp non-steroidal antiandrogen antiandrogens developed structurally related thalidomide383940 historyedit thalidomide developed german pharmaceutical company chemie grnenthal grnenthal gmbh444 obtaining twenty-year patent april 1954 chemie grnenthal started clinical trials early november 1956 marketed thalidomide treatment respiratory infections trade grippex combination drug contained thalidomide quinine vitamin phenacetin acetylsalicylic-acid aspirin researchers chemie grnenthal found thalidomide effective antiemetic inhibitory effect morning sickness45 october 1 1957 company launched thalidomide began aggressively marketing trade contergan46 proclaimed wonder drug insomnia coughs colds headaches time period medications pregnancy strictly controlled drugs tested potential harm fetus45 thousands pregnant women took drug relieve symptoms time drugs development scientists believe drug pregnant woman pass placental barrier harm developing fetus6 effect alcohol fetal development documented case studies alcoholic mothers 1957.47 soon appeared reports findings abnormalities children born traced back drug thalidomide late 1959 noticed peripheral neuritis developed patients took drug period time point thalidomide ceased provided counter48 initially considered safe drug responsible teratogenic deformities children born mothers pregnancies prior trimester november 1961 thalidomide market due massive pressure press public49 experts estimate drug thalidomide led death approximately 2,000 children birth defects 10,000 children 5,000 west germany regulatory authorities east germany approve thalidomide4dead link reason initially unobserved side effects drug subsequent approval west germany time drugs tested teratogenic effects tested rodents usual time50 uk british pharmaceutical company distillers company biochemicals subsidiary distillers part diageo plc marketed thalidomide brand distaval remedy morning sickness united kingdom australia zealand advertisement claimed distaval complete safety pregnant women nursing mothers adverse effect mother childoutstandingly safe distaval prescribed nearly years country4dead link world pharmaceutical companies started produce market drug license chemie grnenthal mid 1950s 14 pharmaceutical companies marketing thalidomide 46 countries 37 reports suggest 51 trade names representatives chemie grnenthal approached smith kline french skf glaxosmithkline gsk request market distribute drug north america memorandum rediscovered 2010 archives food drug administration fda shows part in-licensing approach smith kline french conducted animal tests ran clinical trial drug united states involving 875 people including pregnant women 195657.citation needed 1956 researchers skf involved clinical trials noted high doses thalidomide induce sleep micecitation needed administered doses 50 650 times larger claimed chemie grnenthal sleep inducing researchers achieve hypnotic effect animals humanscitation needed completion trial based reasons hidden decades skf declined commercialize drug later chemie grnenthal 1958 reached agreement william merrell company cincinnati ohio later richardson-merrell part sanofi market distribute thalidomide united states4dead link fda refused approve thalidomide marketing distribution drug distributed large quantities testing purposes american distributor manufacturer richardson-merrell applied approval september 1960.citation needed official charge fda review frances oldham kelsey rely information company include test results richardson-merrell called perform tests report results company demanded approval times refused time total 17 children thalidomide-induced malformations born us51 canada history drug thalidomide dates back april 1 1961 forms sold common variant talimol52 months talimol sale pharmaceutical companies physicians letters warning risk birth defects52 march 2 1962 drugs banned canadian market fdd soon afterward physicians warned destroy supplies52 leprosy treatmentedit 1964 israeli physician jacob sheskin administered thalidomide patient critically ill leprosy patient exhibited erythema nodosum leprosumenl painful skin condition complications leprosy attempted despite ban thalidomides results favourable patient slept hours able bed aid awakening clinical trial studying thalidomide leprosy soon followed53 thalidomide brazilian physicians drug choice treatment severe enl 1965 1996 33 cases thalidomide embryopathy recorded people born brazil 1965.54 1994 production dispensing prescription thalidomide strictly controlled requiring women forms birth control submit regular pregnancy tests despite cases thalidomide embryopathy continue5556 100 cases identified brazil 2005 2010.57 5.8 million thalidomide pills distributed brazil time period largely poor brazilians areas poor access healthcare cases occurred despite controls 1998 fda approved drugs treatment enl58 thalidomides potential causing birth defects drug distributed tightly controlled conditions fda required celgene corporation planned market thalidomide brand thalomid establish system thalidomide education prescribing safety steps oversight program conditions required program include limiting prescription dispensing rights authorized prescribers pharmacies keeping registry patients prescribed thalidomide providing extensive patient education risks drug providing periodic pregnancy tests women take drug58 2010 world health organisation stated recommend thalidomide due difficulty adequately controlling due availability clofazimine59 cancer treatmentedit shortly teratogenic properties thalidomide recognized mid-1960s anti-cancer potential explored clinical trials conducted people advanced cancer including people multiple myeloma trials inconclusive60 work thalidomide cancer 1990s.60 judah folkman pioneered studies role angiogenesis proliferation growth blood vessels development cancer early 1970s shown solid tumors expand it6162 1993 surprised scientific world hypothesizing true blood cancers63 year published work showing biomarker angiogenesis higher people cancer especially high people blood cancers evidence emerged well63 member lab robert damato looking angiogenesis inhibitors discovered 1994 thalidomide inhibited angiogenesis2664 time wife man dying multiple myeloma standard treatments failed called folkman asking anti-angiogenesis ideas62 folkman convinced patients doctor try thalidomide doctor conducted clinical trial thalidomide people multiple myeloma subjects responded treatment62 results trial published england journal medicine 1999.6265 work celgene 2006 usfood drug administration granted accelerated approval thalidomide combination dexamethasone treatment newly diagnosed multiple myeloma patients6266 thalidomide analogsedit main article development analogs thalidomide exploration antiangiogenic immunomodulatory activities thalidomide led study creation thalidomide analogs6768 celgene sponsored numerous clinical trials analogues thalidomide lenalidomide substantially powerful fewer side effects greater myelosuppression69 2005 celgene received fda approval lenalidomide revlimid commercially derivative revlimid restricted distribution setting avoid pregnancy studies conducted find safer compounds qualities potent analog pomalidomide fda approved70 additionally apremilast approved fda march 2014 thalidomide analogs treat diseases regimen fight conditions71 interest turned pomalidomide derivative thalidomide marketed celgene active anti-angiogenic agent 68 acts immunomodulator pomalidomide approved february 2013 food drug administration fda treatment relapsed refractory multiple myeloma72 received similar approval european commission august 2013 expected marketed europe brand imnovid73 society cultureedit regulatory approved usesedit indications thalidomide labelled indication usa fdadate1415 australia tga date17 european union ema date 74 literature supportnotes crohns disease children adolescents small randomised clinical trial75 adults open-label clinical trials76 erythema nodosum leprosum enl yes 1998 yes 2009 literature support including randomised placebo-controlled trials777879 graft versus host disease gvhd limited literature support76 hematopoietic stem cell transplantation hiv-associated wasting syndrome kaposis sarcoma ks rare soft tissue cancer commonly seen immunocompromised caused kaposis sarcoma-associated herpesvirus kshv phase ii study confirmed efficacy80 multiple myeloma yes 2006 yes 2009 yes 2008 numerous clinical trials confirmed efficacy combination medications76 mycobacterial infection mycobacterial infections include lepropsy tuberculosis mycobacterium avium complex mac infections myelodysplastic syndrome primary brain malignancy recurrent aphthous ulcers designated orphan drug orphan drug act 1983 birth defects crisisedit baby born mother thalidomide pregnant late 1950s early 1960s 10,000 children 46 countries born deformities phocomelia consequence thalidomide use81 severity location deformities depended days pregnancy mother thalidomide 20th day pregnancy caused central brain damage day 21 damage eyes day 22 ears face day 24 arms leg damage occur day 28 thalidomide damage foetus 42 days gestation49 known exactly worldwide victims drug estimates range 10,000 20,00035 100,000.49 despite side effects thalidomide sold pharmacies canada 19625282 artificial limbs made affected child 1960s department health social securitys limb fitting centre roehampton london united kingdom drug licensed 1958 withdrawn 1961 approximately 2,000 babies born defects half died months 466 survived 2010.83 spain thalidomide widely 1970s 1980s reasons state controls safeguarding poor 2008 government admitted country imported thalidomide grnenthal failed insist sister company madrid warn spanish doctors permitted warn spanish advocacy group victims thalidomide estimates 2015 250300 living victims thalidomide spain84 australian obstetrician william mcbride german paediatrician widukind lenz suspected link birth defects drug theory lenz proved 1961.8586 mcbride later awarded number honors including medal prize money linstitut de la vie paris87 animal tests conducted dr george somers chief pharmacologist distillers company britain showed foetal abnormalities rabbits88 similar results published showing effects rats8990 species91 east germany head central pharmacy control commission friedrich jung suspected antivitaminic effect thalidomide derivative glutamic acid92 west germany took time increase dysmelia end 1950s connected thalidomide 1958 karl beck pediatric doctor bayreuth wrote article local newspaper claiming relationship nuclear weapons testing cases dysmelia children93 based fdp whip erich mende requested official statement federal government93 statistical reasons main data series research dysmelia cases started chance time approval date thalidomide93 nazi regime law prevention hereditarily diseased offspring mandatory statistical monitoring commit crimes western germany reluctant monitor congenital disorders similarly strict way94 parliamentary report rejected relation radioactivity abnormal increase dysmelia93 dfg research project installed mende request helpful project led pathologist franz bchner ran project propagate teratological theory bchner saw lack healthy nutrition behavior mothers important genetic reasons94 took install surgeon general germany federal ministry health germany founded 1962 months thalidomide banned market93 germany approximately 2,500 thalidomide babies born86 countries restricted drugs approved ingeborg eichler member austrian pharmaceutical admission conference enforced thalidomide tradename softenon sold rules prescription medication result affected children born austria switzerland95 united states pharmacologist frances oldham kelsey md withstood pressure richardson-merrell company refused food drug administration fda approval market thalidomide saying studies needed81 reduced impact thalidomide united states patients thalidomide approved sale united states time millions tablets distributed physicians clinical testing program impossible know pregnant women drug help alleviate morning sickness sedative96 aftermath scandaledit numerous reports malformations babies brought awareness side effects drug pregnant women birth defects caused drug thalidomide range moderate malformation severe forms birth defects include phocomelia dysmelia amelia bone hypoplasticity congenital defects affecting ear heart internal organs45 franks al looked drug affected newborn babies severity deformities reviewed drug early years webb 1963 reviewed history drug forms birth defects caused common form birth defects thalidomide shortened limbs arms frequently affected syndrome presence deformities long bones limbs resulting shortening abnormalities52 germanyedit 1968 large criminal trial began germany charging grnenthal officials negligent homicide injury grnenthal settled victims april 1970 trial ended december 1970 finding guilt part settlement grnenthal paid 100 million dm special foundation german government added 320 million dm foundation paid victims one-time sum 2,500-25,000 dm depending severity disability monthly stipend 100-450 dm monthly stipends raised substantially paid entirely government foundation run money grnenthal paid 50 million euros foundation 2008 31 august 2012 grnenthal chief executive harald stock phd served chief executive officer grnenthal gmbh january 2009 28 2013 member executive board 28 2013 apologized time producing drug remaining silent birth defects97 ceremony stock unveiled statue disabled child symbolize harmed thalidomide apologized trying reach victims 50years time apology 5,000 6,000 sufferers alive victim advocates called apology insulting late criticized company compensating victims criticized company claim known harm drug caused arguing plenty red flags time98 united kingdomedit 1968 long campaign sunday times compensation settlement uk victims reached distillers company part diageo distributed drug uk99100 compensation distributed thalidomide trust uk substantially increased diageo 2005.101 uk government gave survivors grant 20 million distributed thalidomide trust december 2009.102 australiaedit melbourne woman lynette rowe born limbs leading australian class action lawsuit drugs manufacturer grnenthal fought case heard germany supreme court victoria dismissed grnenthals application 2012 case heard australia hundred australian thalidomide survivors involved class action according rowes lawyer103 17 july 2012 lynette rowe awarded out-of-court settlement believed millions dollars paving class action victims receive compensation 104 canadaedit drug thalidomides birth defects children affected peoples lives events came formation group called thalidomide victims association canada group 120 canadian survivors105106 goal prevent future usage drugs potential harm mothers babies members thalidomide victims association involved steps program aimed prevent teratogenicity45 effects thalidomide increased fears regarding safety pharmaceutical drugs society toxicology canada formed effects thalidomide made public focusing toxicology discipline separate pharmacology107 need testing approval toxins pharmaceutical drugs important disaster society toxicology canada responsible conservation environment protection act focusing researching impact human health chemical substances107 thalidomide brought drugs tested type drugs pregnancy increased awareness potential side effects drugs according canadian news magazine program w5 victims thalidomide receive annual benefits compensation government canada excluded provide documentation government requires108 united statesedit 1962 fda pharmacologist frances oldham kelsey receives presidents award distinguished federal civilian service president john kennedy blocking sale thalidomide united states correctly denying application despite pressure richardson-merrell kelsey eventually received presidents award distinguished federal civilian service 1962 ceremony president john kennedy september 2010 fda honored kelsey kelsey award award annually fda staff member came 50 years kelsey medical officer agency reviewed application william merrell company cincinnati109 cardiologist helen taussig learned damaging effects drug thalidomide newborns 1967 testified congress matter trip germany worked infants phocomelia severe limb deformities result efforts thalidomide banned united states europecitation needed notable casesedit niko von glasow german filmmaker mat fraser musician actor performance artist born phocomelia armscitation needed alvin law radio broadcaster born armscitation needed tony melndez singer guitarist plays feet thomas quasthoff internationally acclaimed bass-baritone describes 1.34 meters tall short arms fingers left large well-formed head brown eyes distinctive lips profession singer110 niko von glasow produced documentary called nobodys perfect based lives 12 people affected drug released 2008.111112 terry wiles born phocomelia arms legs known internationally television drama giants shoulders best-selling book namecitation needed lorraine mercer mbe united kingdom born phocomelia arms legs thalidomide survivor carry olympic torch113 change drug regulationsedit disaster prompted countries introduce tougher rules testing licensing drugs kefauver harris amendment114 directive 6565eec1 eu115 united states regulations strengthened fda ways requiring applicants prove efficacy disclose side-effects encountered testing81 fda subsequently initiated drug efficacy study implementation reclassify drugs market researchedit investigational include aids wasting syndrome116 diarrhoea117 kaposis sarcoma76 renal cell carcinoma rcc76118 glioblastoma multiforme76 prostate cancer76 melanoma76 colorectal cancer76 crohns disease76 rheumatoid arthritis76 behcets syndrome119 breast cancer76 head neck cancer76 ovarian cancer76 chronic heart failure76 graft-versus-host disease76 alsoedit immunomodulatory drug discovery development thalidomide analogs drug resort health crisis holt-oram syndrome categorypeople phocomelia diethylstilbestrol referencesedit thalidomide oxford english dictionary 3rd ed oxford university press september 2005.subscription uk public library membership required teo sk colburn wa tracewell wg kook ka stirling di jaworsky ms scheffler ma thomas sd laskin ol 2004 clinical pharmacokinetics thalidomide clin pharmacokinet 43 5 31127 doi10216500003088-200443050-00004 pmid15080764 miller marylin 1991 thalidomide embryopathy model study congenital incomitant horizontal strabismus transaction american ophthalmological society 81 623674 reversal fortune vilified drug life-saving agent war cancer - oncozine - international cancer network november 30 2013dead linkunreliable medical source cuthbert alan 2003 oxford companion body oxford university press doi101093acref97801985240380010001 isbn9780198524038 heaton 1994 chemical industry springer p40 isbn0-7514-0018-1 thalidomide american society health-system pharmacists archived original 2012-09-10 buonsenso serranti valentini october 2010 management central nervous system tuberculosis children light shade pdf european review medical pharmacological sciences 14 10 84553 pmid21222370 archived original pdf 2016-08-18 van toorn solomons march 2014 update diagnosis management tuberculous meningitis children seminars pediatric neurology 21 1 128 doi101016jspen201401006 pmid24655399 srinivasan akobeng ak apr 15 2009 thalidomide thalidomide analogues induction remission crohns disease cochrane database systematic reviews 2 cd007350 doi10100214651858cd007350pub2 pmid19370684 akobeng ak stokkers pc apr 15 2009 thalidomide thalidomide analogues maintenance remission crohns disease cochrane database systematic reviews 2 cd007351 doi10100214651858cd007351pub2 pmid19370685 haas ps denz ihorst engelhardt april 2008 thalidomide consecutive multiple myeloma patients single-center analysis practical aspects efficacy side effects prognostic factors lower thalidomide doses eur haematol 80 4 3039 doi101111j1600-0609200701022x pmid18182082 bennett cl angelotta yarnold pr evens zonder ja raisch dw richardson december 2006 thalidomide- lenalidomide-associated thromboembolism patients cancer jama 296 21 255860 doi101001jama296212558-c pmid17148721 thalomid thalidomide capsule celgene corporation dailymed celgene corporation november 2013 retrieved 17 january 2014 thalomid thalidomide dosing indications interactions adverse effects medscape reference webmd retrieved 17 january 2014 thalidomide celgene 50 mg hard capsules electronic medicines compendium celgene 1 august 2013 retrieved 17 january 2014 thalomid capsules pdf tga ebusiness services celgene pty limited 21 june 2013 retrieved 17 january 2014 myeloma beacon staff 8 april 2011 fda announces investigation revlimid thalidomide secondary cancers myeloma beacon retrieved 17 january 2014 usmani sz sexton hoering heuck cj nair waheed al sayed chauhan ahmad atrash petty van rhee crowley barlogie august 2012 malignancies total therapy 2 3 newly diagnosed multiple myeloma influence thalidomide lenalidomide maintenance blood 120 8 15971600 doi101182blood-2012-04-421883 pmc3429303 pmid22674807 thalidomide risk primary malignancies medicines healthcare products regulatory agency 2013 retrieved 17 january 2014 thalidomide drug label warn cancer risk cbc news 22 2013 kim james scialli anthony 2011 thalidomide tragedy birth defects effective treatment disease toxicological sciences 122 1 16 doi101093toxscikfr088 pmid21507989 singhal mehta february 2002 thalidomide cancer biomedicine pharmacotherapy 56 1 412 doi101016s0753-33220100146-9 pmid11905508 sarno en grau ge vieira lm nery ja april 1991 serum levels tumour necrosis factor-alpha interleukin-1 beta leprosy reactional states clin exp immunol 84 1 1038 doi101111j1365-22491991tb08131x pmc1535359 pmid2015700 stephens td bunde cj fillmore bj june 2000 mechanism action thalidomide teratogenesis biochem pharmacol 59 12 148999 doi101016s0006-29529900388-3 pmid10799645 damato rj loughnan ms flynn folkman 1994 thalidomide inhibitor angiogenesis proceedings national academy sciences united states america 91 9 40824085 bibcode1994pnas914082d doi101073pnas9194082 pmc43727 pmid7513432 therapontos erskine gardner er figg wd vargesson 2009 thalidomide induces limb defects preventing angiogenic outgrowth early limb formation proc natl acad sci usa 106 21 85738 bibcode2009pnas1068573t doi101073pnas0901505106 jstor40482723 pmc2688998 pmid19433787 vargesson 2015 thalidomide-induced teratogenesis history mechanisms birth defects res embryo today 105 2 14056 doi101002bdrc21096 pmc4737249 pmid26043938 eriksson bjrkman roth fyge hglund 1995 stereospecific determination chiral inversion vitro pharmacokinetics humans enantiomers thalidomide chirality 7 1 4452 doi101002chir530070109 pmid7702998 muller gw corral lg shire mg wang moreira kaplan stirling di august 1996 structural modifications thalidomide produce analogs enhanced tumor necrosis factor inhibitory activity med chem 39 17 323840 doi101021jm9603328 pmid8765505 man hw corral lg stirling di muller gw october 2003 alpha-fluoro-substituted thalidomide analogues bioorg med chem lett 13 20 34157 doi101016s0960-894x0300778-9 pmid14505639 bartlett jb dredge dalgleish ag april 2004 evolution thalidomide imid derivatives anticancer agents nat rev cancer 4 4 31422 doi101038nrc1323 pmid15057291 man hw schafer wong lm patterson rt corral lg raymon blease leisten shirley ma tang babusis dm chen stirling muller gw march 2009 discovery s-n-2-1-3-ethoxy-4-methoxyphenyl-2-methanesulfonylethyl-13-dioxo-23-dihydro-1h-isoindol-4-yl acetamide apremilast potent orally active phosphodiesterase 4 tumor necrosis factor-alpha inhibitor med chem 52 6 15224 doi101021jm900210d pmid19256507 httpwwwuniprotorguniprotq96sw2full citation needed zimmer march 15 2010 answers begin emerge thalidomide caused defects york times retrieved 2010-03-21 report issue science protein known cereblon latched tightly thalidomide kronke jan udeshi namrata narla anupama grauman peter hurst slater mcconkey marie svinkina tanya heckl dirk comer eamon li xiaoyu ciarlo christie hartman emily munshi nikhil schenone monica schreiber stuart carr steven ebert benjamin 2014 lenalidomide selective degradation ikzf1 ikzf3 multiple myeloma cells science 343 6168 3015 bibcode2014sci343301k doi101126science1244851 pmc4077049 pmid24292625 krnke jan fink emma hollenbach paul macbeth kyle hurst slater udeshi namrata chamberlain philip mani man hon wah gandhi anita svinkina tanya schneider rebekka mcconkey marie jrs marcus griffiths elizabeth wetzler meir bullinger lars cathers brian carr steven chopra rajesh ebert benjamin 2015 lenalidomide induces ubiquitination degradation ck1 del5q mds nature 523 7559 1838 bibcode2015natur523183k doi101038nature14610 pmc4853910 pmid26131937 hashimoto tanatani nagasawa miyachi 2004 thalidomide multitarget drug application template drug design drugs future 29 4 383 doi101358dof200402904792298 issn0377-8282 liu bo su lei geng jingkun liu junjie zhao guisen 2010 developments nonsteroidal antiandrogens targeting androgen receptor chemmedchem 5 10 16511661 doi101002cmdc201000259 issn1860-7179 hashimoto yuichi 2003 structural development synthetic retinoids thalidomide-related molecules cancer chemotherapy pharmacology 52 0 1623 doi101007s00280-003-0590-3 issn0344-5704 ghobrial im rajkumar sv 2003 management thalidomide toxicity support oncol 1 3 194205 pmc3134146 pmid15334875 deepinder fnu braunstein glenn 2012 drug-induced gynecomastia evidence-based review expert opinion drug safety 11 5 779795 doi101517147403382012712109 issn1474-0338 pmid22862307 nuttall frank warrier rohit gannon mary 2015 gynecomastia drugs critical evaluation literature european journal clinical pharmacology 71 5 569578 doi101007s00228-015-1835-x issn0031-6970 thalidomides secret past link nazi germany -oncozine - international oncology network november 30 2013 archived january 4 2014 wayback machine franks michael macpherson gordon figg william 2004 thalidomide lancet 363 9423 180211 doi101016s0140-67360416308-3 pmid15172781 moghe vijay kulkarni ujjwala parmar urvashi 2008 thalidomide pdf bombay hospital journal bombay bombay hospital 50 3 4726 rouquette 1957 cited landesman-dwyer 1982 maternal drinking pregnancy outcome appl res ment retard 3 3 24163 doi1010160270-30928290018-2 pmid7149705 kelsey fo 1967 events thalidomide dent res 46 6 12015 doi10117700220345670460061201 pmid5235007 thalidomide fifty year fight bbc 15 2014 retrieved 13 september 2015 vfa teratogenic effects 6 july 2011 report website food drug administration archived 12 2009 wayback machine webb jf november 1963 canadian thalidomide experience med assoc 89 98792 pmc1921912 pmid14076167 silverman wa august 2002 schizophrenic career monster drug pediatrics 110 2 pt 1 4046 doi101542peds1102404 pmid12165600 castilla eduardo 1996 thalidomide teratogen south america teratology 54 6 2737 doi101002sici1096-9926199702552156aid-tera630co2-1 pmid9098920 paumgartten fj chahoud july 2006 thalidomide embryopathy cases brazil 1965 reprod toxicol 22 1 12 doi101016jreprotox200511007 pmid16427249 correio braziliense january 2006 talidomida volta assustar archived original march 13 2012 crawford angus 23 july 2013 brazils generation thalidomide babies bbc news sheryl gay stolberg 17 july 1998 thalidomide approved treat leprosy seen york times retrieved 8 january 2012 anon thalidomide leprosy wholeprosy elimination retrieved 22 april 2010 kyle ra rajkumar sv mar 2008 multiple myeloma blood 111 6 296272 doi101182blood-2007-10-078022 pmc2265446 pmid18332230 patricia donahoe judah folkman 19332008 biographical memoir national academy sciences 2014 bielenberg dr damore pa 2008 judah folkmans contribution inhibition angiogenesis lymphat res biol 6 34 2037 doi101089lrb20081016 pmid19093793 folkman dec 2001 angiogenesis-dependent diseases semin oncol 28 6 53642 doi101016s0093-77540190021-1 pmid11740806 ribatti 2008 judah folkman pioneer study angiogenesis angiogenesis 11 1 310 doi101007s10456-008-9092-6 pmc2268723 pmid18247146 singhal mehta desikan ayers roberson eddlemon munshi anaissie wilson dhodapkar zeddis barlogie november 1999 antitumor activity thalidomide refractory multiple myeloma engl med 341 21 156571 doi101056nejm199911183412102 pmid10564685 fda approval thalidomide national cancer institute retrieved 8 january 2012 shah jh swartz gm papathanassiu ae treston fogler madsen jw green sj 1999 synthesis enantiomeric separation 2-phthalimidino-glutaric acid analogues potent inhibitors tumor metastasis med chem 42 16 30147 doi101021jm990083y pmid10447943 damato rj lentzsch anderson kc rogers ms 2001 mechanism action thalidomide 3-aminothalidomide multiple myeloma seminars oncology 28 6 597601 doi101016s0093-77540190031-4 pmid11740816 rao kv september 2007 lenalidomide treatment multiple myeloma health syst pharm 64 17 1799807 doi102146ajhp070029 pmid17724360 search pomalidomide clinicaltrialsgov retrieved 2012-09-01 raghupathy billett hh march 2009 promising therapies sickle cell disease cardiovasc hematol disord drug targets 9 1 18 doi102174187152909787581354 pmid19275572 pomalyst pomalidomide approved fda relapsed refractory multiple myeloma myeloma beacon retrieved 2013-08-10 pomalidomide approved europe relapsed refractory multiple myeloma myeloma beacon retrieved 2013-08-10 thalidomide celgene epar - product information pdf european medicines agency celgene europe limited 29 august 2013 retrieved 19 january 2014 lewis 26 november 2013 thalidomide induced remission early-onset crohns disease medscape medical news webmd retrieved 19 january 2014 franks macpherson gr figg wd 2004 thalidomide lancet 363 9423 18021811 doi101016s0140-67360416308-3 pmid15172781 okafor mc 2003 thalidomide erythema nodosum leprosum applications medscape medical news webmd retrieved 19 january 2014 waters mf march 1971 internally-controlled double blind trial thalidomide severe erythema nodosum leprosum leprosy review 42 1 2642 pmid4338720 villahermosa lg fajardo tt abalos rm balagon mv tan ev cellona rv palmer jp wittes thomas sd kook ka walsh gp walsh ds 2005 randomized double-blind double-dummy controlled dose comparison thalidomide treatment erythema nodosum leprosum american journal tropical medicine hygiene 72 5 518526 pmid15891124 rose lj fishman ad sparano ja 11 march 2013 talavera mckenna harris je eds kaposi sarcoma treatment management medscape reference webmd retrieved 19 january 2014 bren 2001-02-28 frances oldham kelsey fda medical reviewer leaves mark history fda consumer food drug administration retrieved 2009-12-23 turning points historyprescription disaster history television archived original september 29 2011 retrieved 24 february 2010 apology thalidomide survivors bbcnewshealth bbc news 14 january 2010 retrieved 2010-01-14 scott caroline haupt oliver 3 2015 forgotten victims sunday times magazine pp1219 retrieved 8 2015 anon widukind lenz ole daniel enersen retrieved 2009-05-01 anon 2002-06-07 thalidomide40 years bbc news bbc retrieved 2009-05-01 report thalidomide university south wales embryologymedunsweduau retrieved 2012-12-30 somers 1963 foetal toxicity thalidomide proc european soc study drug toxicity 1 49 king ctg kendrick fj 1962 teratogenic effects thalidomide sprague dawley rat lancet 280 7265 1116 doi101016s0140-67366290822-x mccoll globus robinson 1965 effect therapeutic agents developing rat fetus toxicol appl pharmacol 7 409-17 botting jack april 2015 chapter 18 animals medicine contribution animal experiments control disease openbook publishers isbn9781783741175 retrieved 12 august 2015 ddr-brger schliefen ohne contergan east german citizens slept thalidomide neues deutschland german 4 november 2007 retrieved jun 6 2013 thomann klaus-dieter 2007 die contergan-katastrophe die trgerische sicherheit der harten daten thalidomide disaster false security hard data deutsches rzteblatt german 104 41 a2778 b2454 c2382 archived pdf original december 6 2011 retrieved june 6 2013 die contergankatastrophe eine bilanz nach 40 jahren ludwig zichner michael rauschmann klaus-dieter thomann gabler wissenschaftsverlage 2005 190 seiten 10.000 flle von missbildungen 10,000 cases malformations german orf retrieved june 6 2013 mekdeci betty bendectin part 1 commonly drug caused birth defects archived original 2013-12-18 speech occasion inauguration thalidomide-memorial grnenthal gmbh website archived original 2012-09-01 thalidomide apology insulting campaigners say bbc news september 1 2012 archived original 2016-03-16 ryan caroline 1 april 2004 didnt know bbc newshealth bbc news archived original 2004-07-07 retrieved 2009-05-01 flintoff john-paul march 23 2008 thalidomide battle compensation goes sunday times london times newspapers archived original 2008-05-13 retrieved 2009-05-01 compensation offer thalidomide bbc news 7 july 2005 archived original 2009-01-20 retrieved 26 july 2011 thalidomide survivors 20m bbc news 23 december 2009 archived original 2013-01-14 retrieved 26 july 2011 australian thalidomide victims win hearing abc news 19 december 2011 shears richard 18 july 2012 british drug firm pay millions thalidomide victim born arms legs landmark compensation case result thousands similar claim daily mail retrieved 9 march 2016 warren 2001 living world thalidomide dose reality fda consumer 35 2 40 pmid11444250 thalidomide victims association canada racz wj ecobichon dj baril august 2003 on-line sources toxicological information canada toxicology 190 12 314 doi101016s0300-483x0300192-6 pmid12909394 plight thalidomide sample babies dont qualify govt compensation w5 retrieved 28 november 2016 publics quiet savior harmful medicines york times 13 september 2010 orpheus lives small good thing quastoff portland phoenix april 19 2002 retrieved june 6 2013 nobodys perfect 2008 release info imdb retrieved june 6 2013 brussat frederic brussat mary ann film review nobodys perfect spirituality practice retrieved june 6 2013 tamplin harley 12 june 2015 mid sussex residents honoured queen mid sussex times retrieved 27 december 2015 50 years kefauver-harris amendments food drug administration united states retrieved 6 june 2013 thalidomide national health service england retrieved 6 june 2013 gordon jn trebble tm ellis rd duncan hd johns goggin pm april 2005 effects thalidomide hiv-associated wasting syndrome randomized double-blind placebo-controlled clinical trial gut 54 4 540545 doi101136gut2004047563 pmc1774430 pmid15753541 sharpstone rowbottom francis tovey ellis barrett gazzard june 1997 thalidomide therapy microsporidiosis gastroenterology 112 6 18231829 doi101053gast1997v112pm9178672 pmid9178672 tunio ma hashmi qayyum naimatullah masood september 2012 low-dose thalidomide patients metastatic renal cell carcinoma journal pakistan medical association 62 9 876879 pmid23139966 hamuryudan mat saip ozyazgan siva yurdakul zwingenberger yazici march 1998 thalidomide treatment mucocutaneous lesions behcet syndrome randomized double-blind placebo-controlled trial annals internal medicine 128 6 443450 doi1073260003-4819-128-6-199803150-00004 pmid9499327 readingedit stephens trent brynner rock 2001-12-24 dark remedy impact thalidomide revival vital medicine perseus books isbn0-7382-0590-7 knightley phillip evans harold 1979 suffer children story thalidomide york viking press isbn0-670-68114-8 external linksedit pharmaceuticals newsletter 2 2003 page 11 feature article cbc digital archives thalidomide bitter pills broken promises antiangiogenics endogenous angiopoietin 2 angiostatin canstatin calreticulin endostatin ifn- ifn- ifn- cxcl10 il-4 il-12 il-18 maspin meth-1 meth-2 osteopontin platelet factor-4 prolactin proliferin-related protein prothrombin kringle domain-2 antithrombin iii fragment sparc thrombospondin 1 timp vasostatin vegi soluble vegfr-1 nrp-1 cdai exogenous 2-methoxyestradiol v3 inhibitors angiostatic steroids heparin angiostatin bevacizumab carboxyamidotriazole cartilage-derived angiogenesis inhibitory factor cm101 endostatin ifn- il-12 itraconazole linomide matrix metalloproteinase inhibitors platelet factor-4 prolactin su5416 suramin tasquinimod tecogalan tetrathiomolybdate thalidomide thrombospondin thrombospondin tnp-470 vegfr antagonists angiogenesis angiogenesis inhibitors immunosuppressive drugs immunosuppressants l04 intracellular initiation antimetabolites purine synthesis inhibitors azathioprine mycophenolic acid pyrimidine synthesis inhibitors leflunomide teriflunomide antifolate methotrexate macrolides il-2 inhibitors fkbpcyclophilincalcineurin tacrolimus ciclosporin pimecrolimus abetimus gusperimus imids lenalidomide pomalidomide thalidomide pde4 inhibitor apremilast intracellular reception il-1 receptor antagonists anakinra mtor sirolimus everolimus ridaforolimus temsirolimus umirolimus zotarolimus extracellular antibodies monoclonal serum target noncellular complement component 5 eculizumab tnf adalimumab afelimomab certolizumab pegol golimumab infliximab nerelimomab interleukin 5 mepolizumab immunoglobulin omalizumab interferon faralimomab il-6 elsilimomab il-12 il-23 lebrikizumab ustekinumab il-17a secukinumab cellular target cd3 muromonab-cd3 otelixizumab teplizumab visilizumab cd4 clenoliximab keliximab zanolimumab cd11a efalizumab cd18 erlizumab cd20 obinutuzumab rituximab ocrelizumab pascolizumab cd23 gomiliximab lumiliximab cd40 teneliximab toralizumab cd62ll-selectin aselizumab cd80 galiximab cd147basigin gavilimomab cd154 ruplizumab blys belimumab blisibimod ctla-4 ipilimumab tremelimumab cat bertilimumab lerdelimumab metelimumab integrin natalizumab interleukin-6 receptor tocilizumab lfa-1 odulimomab il-2 receptorcd25 basiliximab daclizumab inolimomab t-lymphocyte zolimomab aritox unsorted atorolimumab cedelizumab fontolizumab maslimomab morolimumab pexelizumab reslizumab rovelizumab siplizumab talizumab telimomab aritox vapaliximab vepalimomab polyclonal anti-thymocyte globulin anti-lymphocyte globulin -cept fusion ctla-4 abatacept belatacept tnf inhibitor etanercept pegsunercept aflibercept alefacept rilonacept androgen receptor modulators ar agonists testosterone derivatives 4-androstenediol 4-androstenedione 4-dehydroepiandrosterone 4-dhea 4-hydroxytestosterone 5-androstenediol 5-androstenedione 11-ketotestosterone 11-hydroxyandrostenedione adrenosterone 11-ketoandrostenedione 11-oxoandrostenedione atamestane boldenone boldenone undecylenate boldione 1,4-androstadienedione clostebol clostebol acetate clostebol caproate clostebol propionate cloxotestosterone cloxotestosterone acetate dhea androstenolone prasterone 5-dhea dhea enanthate prasterone enanthate dhea sulfate exemestane formestane plomestane quinbolone silandrone testosterone testosterone acetate testosterone acetate butyrate testosterone acetate propionate testosterone benzoate testosterone butyrate testosterone buciclate testosterone capropate testosterone cyclohexylpropionate testosterone cypionate testosterone decanoate testosterone diacetate testosterone dipropionate testosterone enanthate testosterone formate testosterone furoate testosterone hexahydrobenzoate testosterone hexahydrobenzylcarbonate testosterone hexyloxyphenylpropionate testosterone isobutyrate testosterone isocaproate testosterone isovalerate testosterone ketolaurate testosterone nicotinate testosterone palmitate testosterone phenylacetate testosterone phenylbutyrate testosterone phenylpropionate testosterone phosphate testosterone propionate testosterone stearate testosterone sulfate testosterone undecanoate testosterone valerate dihydrotestosterone derivatives 1-androstenediol 1-androstenedione 1-androsterone 1-andro 1-dhea 1-testosterone 3-androstanediol 5-androst-2-en-17-one 7-hydroxyepiandrosterone 11-ketodihydrotestosterone androsterone bolazine bolazine capronate dihydrotestosterone androstanolone stanolone dihydrotestosterone acetate dihydrotestosterone benzoate dihydrotestosterone butyrate dihydrotestosterone enanthate dihydrotestosterone formate dihydrotestosterone propionate dihydrotestosterone valerate drostanolone drostanolone propionate epiandrosterone epitiostanol mepitiostane mesabolone mesterolone nisterime nisterime acetate prostanozol stenbolone stenbolone acetate 19-nortestosterone derivatives 7-methyl-19-norandrostenedione ment dione trestione 11-methyl-19-nortestosterone 11-methyl-19-nortestosterone dodecylcarbonate 19-nor-5-androstenediol 19-nor-5-androstenedione bolandiol bolandiol dipropionate bolandione 19-nor-4-androstenedione bolmantalate nandrolone adamantoate dienedione dienolone dimethandrolone dimethandrolone buciclate dimethandrolone dodecylcarbonate dimethandrolone undecanoate ls-1727 nandrolone 17-n-2-chloroethyl-n-nitrosocarbamate methoxydienone methoxygonadiene nandrolone nandrolone acetate nandrolone caproate nandrolone cypionate nandrolone cyclohexanecarboxylate nandrolone cyclohexylpropionate nandrolone cyclotate nandrolone decanoate nandrolone formate nandrolone furylpropionate nandrolone hexyloxyphenylpropionate nandrolone hydrogen succinate nandrolone laurate nandrolone phenylpropionate nandrolone propionate nandrolone sulfate nandrolone sulfate sodium nandrolone undecanoate norclostebol norclostebol acetate normethandrone methylestrenolone normethisterone oxabolone oxabolone cipionate oxabolone cypionate trenbolone trenbolone acetate trenbolone enanthate trenbolone hexahydrobenzylcarbonate trestolone ment trestolone acetate dihydrotestosterone 19-nortestosterone derivatives 5-dihydronandrolone 19-norandrosterone 17-alkylated testosterone derivatives bolasterone calusterone chlorodehydromethylandrostenediol cdma chlorodehydromethyltestosterone cdmt chloromethylandrostenediol cma enestebol ethyltestosterone fluoxymesterone formebolone hydroxystenozole metandienone methandrostenolone methandriol methylandrostenediol methandriol bisenanthoyl acetate methandriol diacetate methandriol dipropionate methandriol propionate methylclostebol chloromethyltestosterone methyltestosterone oxymesterone penmesterol tiomesterone 17-alkylated dihydrotestosterone derivatives androisoxazole desoxymethyltestosterone furazabol mebolazine dimethazine mestanolone metenolone metenolone acetate metenolone enanthate methasterone methyl-1-testosterone methylepitiostanol methylstenbolone oxandrolone oxymetholone stanozolol 17-alkylated 19-nortestosterone derivatives bolenol dimethyltrienolone 7-methylmetribolone 7,17-dimethyltrenbolone ethyldienolone ethylestrenol methyldienolone methylhydroxynandrolone mohn mhn metribolone mibolerone norboletone norethandrolone propetandrol tetrahydrogestrinone 17-vinyltestosterone derivatives norvinisterone vinylnortestosterone vinyltestosterone 17-ethynyltestosterone derivatives 4-tibolone chloroethynyl norgestrel danazol desogestrel ethisterone ethynyltestosterone etonogestrel etynodiol etynodiol diacetate gestodene gestrinone levonorgestrel levonorgestrel butanoate lynestrenol norethisterone norethisterone acetate norethisterone acetate oxime norethisterone enanthate norgestrel norgestrienone quingestanol quingestanol acetate tibolone progesterone derivatives medroxyprogesterone acetate othersunsorted cl-4as-1 mixed sarms non-steroidal 198rl26 acp-105 ac-262356 acetothiolutamide andarine acetamidoxolutamide androxolutamide gtx-007 s-4 bms-564929 enobosarm ostarine mk-2866 gtx-024 s-22 ftbu-1 gsk-4336a gsk-8698 lg-121071 lgd-121071 lgd-2226 lgd-2941 lgd-122941 lgd-3303 lgd-4033 jnj-26146900 jnj-28330835 jnj-37654032 orm-11984 rad140 r-1 r-2 r-3 s-1 s-23 s-40503 s-101479 steroidal mk-0773 tfm-4as-1 yk-11 antagonists steroidal 3-hydroxytibolone 3-hydroxytibolone 9,11-dehydrocortexolone 17-butyrate cb-03-04 11-hydroxyprogesterone 15-hydroxycyproterone acetate abiraterone acetate allyltestosterone benorterone bomt canrenoic acid canrenone chlormadinone acetate clometerone cortexolone 17-propionate cb-03-01 cyproterone cyproterone acetate delanterone dienogest drospirenone edogestrone epitestosterone galeterone guggulsterone medrogestone megestrol acetate mespirenone metogest mexrenone mifepristone nomegestrol acetate nordinone osaterone osaterone acetate oxendolone potassium canrenoate prorenone rosterolone sc-5233 spirolactone spironolactone spirorenone topterone trimethyltrienolone r-2956 zanoterone non-steroidal aa560 apalutamide atraric acid azd-3514 bay-1024767 bicalutamide bisphenols badge bfdge bisphenol bisphenol bisphenol bms-641988 cimetidine cioteronel darolutamide ddt metabolite pp-dde dieldrin dimp endosulfan enzalutamide epi-001 epi-506 fenarimol flutamide hydroxyflutamide inocoterone inocoterone acetate ketoconazole lavender oil lg-105 lg-120907 linuron methiocarb n-butylbenzenesulfonamide n-desmethylenzalutamide nilutamide onc1-13b orm-15341 pentomone pf-998425 phenothrin prochloraz procymidone ru-22930 ru-58642 ru-58841 seviteronel thalidomide topilutamide fluridil valproic acid vinclozolin gprc6a agonists cations incl aluminum calcium gadolinium magnesium strontium dehydroandrosterone dihydrotestosterone estradiol l--amino acids incl l-arginine l-lysine l-ornithine osteocalcin testosterone estrogenics glucocorticoidics mineralocorticoidics progestogenics steroid hormone metabolism modulators list androgensanabolic steroids authority control gnd 4184973-5 ndl 00570209 